EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative Analysis of CXCR5 Circulating DNA Methylation Levels in Autoimmune Rheumatic Diseases

Yiming Shi iD, Yingying Qin, Yunshen Li, Ping Jiang, Kai Wei, Jianan Zhao, Yu Shan, Yixin Zheng, Fuyu Zhao, Mi Zhou, Li Li, Yu Shen und 6 weitere

Immunity, Inflammation and Disease · 2025

DOI: 10.1002/iid3.70128 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Immunity, Inflammation and Disease, 2025. Verfasst von Yiming Shi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: DNA Methylation, Receptors, CXCR5, Autoimmune Diseases, Rheumatic Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was supported by the National Natural Science Funds of China (82074234, 82073901), the State Administration of Traditional Chinese Medicine, the….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess CXC chemokine receptor 5 (CXCR5) circulating DNA methylation differences in autoimmune rheumatic diseases and their relation with clinical features.

Methods

Targeted methylation sequencing was performed using peripheral blood from 164 rheumatoid arthritis (RA), 30 systemic lupus erythematosus (SLE), 30 ankylosing spondylitis (AS), 30 psoriatic arthritis (PsA), 24 Sjögren's syndrome (SS) patients, and 30 healthy controls (HC).

Results

Significant differences in CXCR5 cg19599951 methylation were found between RA and HC, as well as AS and SLE. RA patients exhibited higher methylation than HC and AS ( p < 0.01) but lower than SLE ( p < 0.05). SLE patients showed higher methylation compared to HC, AS, and PsA ( p < 0.001, 0.01, and 0.05, respectively). No significant differences were found in patients with SS compared to other autoimmune diseases and HC. Methylation at cg19599951_103 ( r = 0.17, p < 0.05) and cg19599951_209 ( r = 0.22, p < 0.01), along with the CC haplotype ( r = 0.21, p < 0.01), showed significant positive correlations with erythrocyte sedimentation rate (ESR), while the CT ( r = −0.27, p < 0.001) and TT haplotypes ( r = −0.19, p < 0.05) were negatively correlated. For C‐reactive protein (CRP), methylation at cg19599951_103 ( r = 0.29, p < 0.001) and cg19599951_209 ( r = 0.33, p < 0.0001), and the CC haplotype ( r = 0.34, p < 0.0001) was positively correlated, whereas the CT ( r = −0.36, p < 0.0001) and TT ( r = −0.30, p < 0.0001) haplotypes were negatively correlated. Significant negative correlations were observed between the CT haplotype and rheumatoid factor ( r = −0.25, p < 0.01), and anti‐citrullinated protein antibody ( r = −0.20, p < 0.05). No significant correlations were found in patients with SLE, AS, and SS. Receiver operating characteristic analysis showed CXCR5 methylation could classify patients with RA versus those with AS (AUC: 0.624−0.967).

Conclusion

Differential circulating CXCR5 methylation levels were observed in autoimmune rheumatic diseases, which correlated with inflammatory mediators in RA and may serve as potential biomarkers for RA diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationReceptors, CXCR5Autoimmune DiseasesRheumatic DiseasesHumansFemaleMaleMiddle AgedAdultAgedLupus Erythematosus, SystemicCase-Control StudiesSjogren's Syndrome

Stichwörter der Autor:innen

CXCR5DNA methylationautoimmune rheumatic diseasescirculating methylation levelsinflammation

Substanzen

Receptors, CXCR5CXCR5 protein, human

Autor:innen und Institutionen

  • Department of Rheumatology, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Guanghua Clinical Medical College, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Institute of Arthritis Research in Integrative Medicine, Shanghai Academy of Traditional Chinese Medicine, Shanghai, China.
  • Traditional Chinese Medicine Hospital of Inner Mongolia Autonomous Region, Inner Mongolia Autonomous Region, Hohhot, China.
  • The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosecurity, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Center for Traditional Chinese Medicine and Immunology Research, School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

ORCID-Profile: Yiming Shi

Förderung

  • This research was supported by the National Natural Science Funds of China (82074234, 82073901), the State Administration of Traditional Chinese Medicine, the…

Zitieren

APA

Shi, Y., Qin, Y., Li, Y., Jiang, P., Wei, K., Zhao, J., Shan, Y., Zheng, Y., Zhao, F., Zhou, M., Li, L., Shen, Y., Lv, X., Zheng, Y., Guo, S., Ding, Q., Chang, C., & He, D. (2025). Comparative Analysis of CXCR5 Circulating DNA Methylation Levels in Autoimmune Rheumatic Diseases. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70128

Vancouver

Shi Y, Qin Y, Li Y, Jiang P, Wei K, Zhao J, et al. Comparative Analysis of CXCR5 Circulating DNA Methylation Levels in Autoimmune Rheumatic Diseases. Immunity, Inflammation and Disease. 2025. doi:10.1002/iid3.70128

BibTeX
@article{Shi2025,
  author = {Shi, Yiming and Qin, Yingying and Li, Yunshen and Jiang, Ping and Wei, Kai and Zhao, Jianan and Shan, Yu and Zheng, Yixin and Zhao, Fuyu and Zhou, Mi and Li, Li and Shen, Yu and Lv, Xinliang and Zheng, Yuejuan and Guo, Shicheng and Ding, Qin and Chang, Cen and He, Dongyi},
  title = {Comparative Analysis of CXCR5 Circulating DNA Methylation Levels in Autoimmune Rheumatic Diseases},
  journal = {Immunity, Inflammation and Disease},
  year = {2025},
  doi = {10.1002/iid3.70128}
}
Kostenlos starten →